Molecular mechanism of insulin resistance in obesity and type 2 diabetes

Area of Science:

• Metabolic research
• Molecular biology
• Endocrinology

Background:

• Insulin resistance is a primary risk factor for type 2 diabetes and obesity.
• It stems from impaired insulin signaling in target tissues, particularly skeletal muscle.
• Key signaling pathways involve insulin receptor substrates (IRSs), phosphatidylinositol 3-kinase (PI3K), and Akt.

Purpose of the Study:

• To review the molecular basis of skeletal muscle insulin resistance in obesity and type 2 diabetes.
• To discuss the impact of lifestyle interventions and insulin-sensitizing agents on insulin signaling.
• To address the emerging role of Rho-kinase in insulin action and metabolism.

Main Methods:

• Literature review and synthesis of current research on insulin resistance.
• Analysis of molecular mechanisms in insulin signaling pathways.
• Discussion of clinical interventions and their effects on insulin sensitivity.

Main Results:

• Skeletal muscle insulin resistance is linked to impaired insulin-dependent PI3K activation and downstream signaling.
• Insulin-sensitizing agents and lifestyle changes can modulate insulin signaling cascades.
• Rho-kinase is identified as a novel regulator of insulin action.

Conclusions:

• Understanding the molecular intricacies of skeletal muscle insulin resistance is crucial for developing effective treatments.
• Targeting specific signaling pathways, including those involving Rho-kinase, holds therapeutic potential.
• Combined approaches of pharmacological treatment and lifestyle modification are vital for managing insulin resistance.